Patents by Inventor Collin Bradley Jugler

Collin Bradley Jugler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATING AND CURING COVID-19 INFECTION UTILIZING A LASER
    Publication number: 20230191011
    Abstract: An embodiment provides a method for treating a body fluid of a patient with Covid-19, including: removing the body fluid from a patient; applying a treatment to the body fluid, wherein the treatment comprises an antibody that joins with a virion in the body fluid to form an antibody-virion complex, wherein the antibody comprises a tag sensitive to an illumination; removing the antibody-virion complex from the body fluid using an illumination source; and returning the body fluid to the patient. Other aspects are described and claimed.
    Type: Application
    Filed: April 21, 2021
    Publication date: June 22, 2023
    Inventors: Qiang Chen, Collin Bradley Jugler, Haiyan Sun, Adrian Esqueda, Mitchell S. Felder
  • COVID-19 INFLAMMATORY CYTOKINE STORM TREATMENT
    Publication number: 20230148395
    Abstract: An embodiment provides a method for treating a body fluid of a patient with an inflammatory cytokine storm, including: removing the body fluid from a patient; applying a treatment to the body fluid, wherein the treatment comprises an antibody that joins with an antigen in the body fluid to form an antibody -antigen complex; removing the antibody-antigen complex from the body fluid; and returning the body fluid to the patient. Other aspects are described and claimed.
    Type: Application
    Filed: April 8, 2021
    Publication date: May 11, 2023
    Inventors: Qiang Chen, Collin Bradley Jugler, Haiyan Sun, Adrian Esqueda, Mitchell S. Felder
  • ANTIBODY ASSAY FOR SARS-CoV-2
    Publication number: 20220341932
    Abstract: An embodiment provides a method for detection of viral antigen for the COVID-19 virus, including: obtaining a body fluid from a patient; introducing the body fluid to at least one binding antibody, wherein the at least one binding antibody binds to an antigen of the SARS-CoV-2 spike (S) protein and comprises an indicator; forming a viral antigen—antibody complex; and determining the presence of the viral antigen—antibody complex. Other aspects are described and claimed.
    Type: Application
    Filed: April 21, 2022
    Publication date: October 27, 2022
    Inventors: Qiang Chen, Haiyan Sun, Collin Bradley Jugler, Adrian Esqueda, Mitchell Steven Felder